Suppr超能文献

在冠状动脉搭桥手术中,抑肽酶对冷停搏液并无额外的保护作用。

Aprotinin does not add protective effect to cold cardioplegia during coronary artery bypass surgery.

作者信息

Hjelms E, Waldorff S, Steiness E, Bergsten O

出版信息

Scand J Thorac Cardiovasc Surg. 1986;20(1):11-3. doi: 10.3109/14017438609105909.

Abstract

The effect of aprotinin on intraoperative and postoperative CK-MB and left ventricular contractility in terms of dp/dt response to atrial pacing up to 150 beats/min was studied in 20 patients randomized before aortocoronary bypass surgery to either aprotinin or placebo administration. Cold cardioplegia and topical deep hypothermia were used in both groups. No difference could be demonstrated between the aprotinin and the placebo group, and the authors therefore concluded that aprotinin does not add substantially to the protective effect of cold cardioplegia and deep topical hypothermia during aortocoronary bypass surgery.

摘要

在20例接受主动脉冠状动脉搭桥手术的患者中,研究了抑肽酶对术中和术后肌酸激酶同工酶(CK-MB)以及左心室收缩力的影响,具体是观察在心房起搏频率高达150次/分钟时dp/dt的反应。这些患者在手术前被随机分为两组,分别接受抑肽酶或安慰剂治疗。两组均采用冷心脏停搏液和局部深低温技术。结果显示,抑肽酶组和安慰剂组之间没有差异,因此作者得出结论,在主动脉冠状动脉搭桥手术中,抑肽酶并不能显著增强冷心脏停搏液和局部深低温的保护作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验